Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
Rang in Aktien #12609
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Aktienkurs
$1.29
Marktkapitalisierung
$567.34M
Veränderung (1 Tag)
-1.33%
Veränderung (1 Jahr)
-20.72%
Land
CN
Handel Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

Kategorie

Kursverlauf für Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)
Höchster Schlusskurs: $1.30 am 2026-08-01

Niedrigster Schlusskurs: $1.81 am 2016-03-01
Kursverlauf der Aktie von Zhejiang Starry Pharmaceutical Co.,Ltd. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 9.49%
2025 2.59%
2024 -35.49%
2023 -25.23%
2022 -60.98%
2021 -5.21%
2020 140.70%
2019 113.70%
2018 -9.58%
2017 -37.64%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.61 25.11%
JP
$222.33 27.49%
CH
$21.22 17.31%
IN